Keystone Folding Box Co. and Med-Con Technologies have partnered to integrate Med-Con's digital adherence monitoring ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...

Discover how a 5-day fasting-mimicking diet revolutionizes type 2 diabetes management, reducing medications and improving ...

Keystone Folding Box Co., a provider of paperboard packaging solutions, has partnered with Med-Con Technologies, a provider ...

Beyond helping diabetes patients lose weight and control blood sugar, semaglutide appears to cut dementia risk by nearly half ...

Of the 102,166 GLP-1s analyzed, 94% had some form of commercial insurance, yet cost-saving options were still widely overlooked.

Specific factors, including deep sleep and daytime urinary control, are associated with treatment-responsive nocturnal ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

The study suggests that digital inhalers may reduce the incidence of severe asthma exacerbations, particularly in patients at ...

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

This is Prime Therapeutics’ latest research into GLP-1s and the long term impact of taking the medication. In October of last ...